文献速递心脑血管急症重症综合管理与镇静镇痛

氯胺酮镇静镇痛对重型颅脑创伤患者神经结局的影响:一项随机对照先导研究

Effect of Ketamine Analgosedation on Neurological Outcome in patients with Severe Traumatic Brain Injury: A Randomized Controlled Pilot Study.
PubMed 文献 · Neurocrit Care · 2025-05-13
一句话结论重型颅脑创伤患者持续输注氯胺酮3 mg/kg/h未改善3个月神经结局,仅前4-6小时血压与脑灌注压较高、第4-6小时颅内压短暂降低,6小时后效应未维持。

该随机对照先导研究纳入60例重型颅脑创伤成人患者,随机接受氯胺酮3 mg/kg/h持续输注或生理盐水,在颅内压监测期间比较全身血流动力学、动脉血气、颅内压、脑灌注压和颈静脉血氧饱和度。结果显示,初始4-6小时内氯胺酮组血压和脑灌注压显著高于对照组,但6小时后效应未维持;颅内压仅在第四至第六小时短暂显著降低;对照组更常使用血管升压药(13例[43.3%] vs 5例[16.6%],P=0.02);3个月时两组神经结局无差异。作者结论认为氯胺酮输注未显著改善重型颅脑创伤患者的神经结局,脑灌注压改善和颅内压降低趋势未达统计学显著。

要点

  • 重型颅脑创伤成人患者持续输注氯胺酮3 mg/kg/h,3个月神经结局与生理盐水组无差异。
  • 氯胺酮组初始4-6小时血压和脑灌注压显著高于对照组,但6小时后效应未维持。
  • 颅内压仅在第四至第六小时短暂显著降低,之后无持续差异。
  • 对照组血管升压药使用更多:13例(43.3%)vs 5例(16.6%),P=0.02。
  • 氯胺酮组脑灌注压改善和颅内压降低趋势未达统计学显著。

适用人群与场景

  • 60例重型颅脑创伤成人患者,随机接受氯胺酮3 mg/kg/h持续输注或生理盐水,输注期间进行颅内压监测。

处置流程与药物剂量

  • 氯胺酮组:氯胺酮以3 mg/kg/h持续输注,在颅内压监测期间给药。
  • 对照组:给予生理盐水输注。
  • 监测指标包括全身血流动力学、动脉血气、颅内压、脑灌注压和颈静脉血氧饱和度。
  • 3个月时由独立观察者使用扩展格拉斯哥结局量表记录神经结局。

研究设计与关键结果

  • 研究类型:随机对照先导研究,样本量60例成人重型颅脑创伤患者,随机分为氯胺酮3 mg/kg/h输注组和生理盐水对照组。
  • 基线血流动力学参数两组相当。
  • 初始4-6小时氯胺酮组血压和脑灌注压显著高于对照组,但6小时后效应未维持。
  • 颅内压仅在第四至第六小时短暂显著降低。
  • 血管升压药使用:对照组13例(43.3%)vs 氯胺酮组5例(16.6%),P=0.02。
  • 3个月神经结局(扩展格拉斯哥结局量表)两组无差异。
  • 作者结论:氯胺酮输注未显著改善神经结局,脑灌注压改善和颅内压降低趋势未达统计学显著。

证据类型、等级与局限

  • 证据类型:随机对照先导研究。
  • 试验注册:印度中央试验注册中心(CTRI/2018/09/015729)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,重型颅脑创伤患者持续输注氯胺酮3 mg/kg/h未显著改善3个月神经结局,脑灌注压改善和颅内压降低趋势未达统计学显著。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Most of the sedative and analgesic drugs used in patients with head injury cause a dose-dependent decrease in blood pressure, which may further worsen secondary neurologic injury. The sympathomimetic profile of ketamine, along with its neuroprotectant effect, can have a beneficial effect in these patients.

METHODS: A total of 60 adult patients with severe traumatic brain injury were randomized to receive either ketamine infusion at 3 mg/kg/h or normal saline. The study drugs were given by infusion while intracranial pressure (ICP) monitoring was going on. Systemic hemodynamics, arterial blood gas values, ICP, cerebral perfusion pressure (CPP), and jugular venous oxygen saturation were monitored. At the end of 3 months, neurological outcome was recorded by an independent observer using the Glasgow Outcome Scale-Extended.

RESULTS: Baseline values of hemodynamic parameters were comparable in the two groups. In the initial 4-6 h, patients in the ketamine group had a significantly higher level of blood pressure and CPP than patients in the control group, but the effect was not sustained after 6 h. Similarly, a significant reduction in ICP was observed only for a brief period, between the fourth and sixth hours. Vasopressors were more often used in the control group (13 [43.3%] vs. 5 [16.6%]; p = 0.02). There was no difference in the neurological outcome at 3 months in both groups.

CONCLUSIONS: There was no significant improvement in neurological outcome with ketamine infusion in patients with severe traumatic brain injury. There was a trend toward better CPP and lower ICP; however, the difference was statistically insignificant. Trial registered at Central Trial Registry of India (CTRI/2018/09/015729) at https://ctri.nic.in/Clinicaltrials/.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Burman S, Chouhan RS, Kumar N, et al. Effect of Ketamine Analgosedation on Neurological Outcome in patients with Severe Traumatic Brain Injury: A Randomized Controlled Pilot Study. Neurocrit Care. 2025. PMID: 40355795. doi:10.1007/s12028-025-02274-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。